IDH1 and central nervous system cancer: Previous study by Pollack and colleagues reported that IDH1 mutation was common in adolescent malignant gliomas in which 16.3% of high grade gliomas between 3 to 21 years harbored the mutation and was significantly associated with age greater than 14 years [28].